Survival analysis suggested GC patients with high-regulated YTHDF1 (TMA1 cohort) or USP14 (TCGA cohort) expression exhibited worse overall survival as compared with patients having low YTHDF1 or USP14 expression (Figures 5G, 7F). The gene discussed is USP14; the disease is gastric cancer.